Direct genomic manipulation at a specific locus is still not feasible in most vertebrate model organisms. In vertebrate cell lines, genomic lesions at a specific site have been introduced using zinc-finger nucleases (ZFNs) 1-3 . Here we adapt this technology to create targeted mutations in the zebrafish germ line. ZFNs were engineered that recognize sequences in the zebrafish ortholog of the vascular endothelial growth factor-2 receptor, kdr (also known as kdra). Co-injection of mRNAs encoding these ZFNs into one-cell-stage zebrafish embryos led to mutagenic lesions at the target site that were transmitted through the germ line with high frequency. The use of engineered ZFNs to introduce heritable mutations into a genome obviates the need for embryonic stem cell lines and should be applicable to most animal species for which earlystage embryos are easily accessible.
The ability to perform targeted genomic manipulation in the mouse using embryonic stem cell lines has established it as a central vertebrate model system 4, 5 . Similar manipulations in other vertebrate models have largely failed owing to the difficulty of generating embryonic stem cell lines. ZFNs, which are a chimeric fusion between a Cys 2 His 2 zinc-finger protein (ZFP) and the cleavage domain of FokI endonuclease 1, 6 , are useful tools for genomic manipulation in plants 7, 8 , invertebrates 9, 10 and cell lines 2, 3, 11 . The DNA-binding specificity is supplied by the ZFP, which can be engineered to recognize a wide variety of target sequences [12] [13] [14] [15] , and the cleavage activity is provided by the nuclease domain 1, 6 . The nuclease domain requires dimerization for activity, and consequently two ZFNs must assemble on DNA with the appropriate geometry for efficient DNA cleavage 16 ( Supplementary Fig. 1a online) . ZFN-mediated cleavage can lead to mutations when double-stranded breaks are repaired by nonhomologous end joining (NHEJ), an error-prone repair pathway 10, 17 . Thus, ZFNs allow directed mutagenesis of a desired target sequence in a complex genome.
Here we test the feasibility of this approach for introducing targeted mutations in the germ line of zebrafish. The external fertilization of zebrafish embryos makes them accessible for injection with mRNAs encoding ZFNs. We reasoned that injection into one-cell-stage embryos would induce lesions early enough in development that they would be transmitted through the zebrafish germ line. We chose to target the zebrafish kdr locus because of the availability of N-ethyl-N-nitrosourea-induced mutant alleles that display vascular-specific embryonic defects (ref. 18 and data not shown). We first developed an algorithm that identifies sites within a desired sequence that have favorable properties for recognition and cleavage by a pair of ZFNs ( Supplementary Fig. 2 online) . Using this approach, we identified two 9-base-pair (bp) zinc-finger recognition elements flanking a 6-bp spacer within kdr exon 2 ( Supplementary Fig. 1c ). As this exon encodes the N-terminal region of the extracellular domain of the Kdr receptor tyrosine kinase, we would expect frameshift mutations at this site to generate a null allele.
We used a combination of design and selection to create threefinger ZFPs with good DNA-binding specificity for each 9-bp recognition element within kdr exon 2 ( Fig. 1) . As a first step, we selected individual fingers to recognize each 3-bp subsite within the 9-bp recognition element using a bacterial one-hybrid system (Supplementary Methods online). For this purpose we constructed libraries for each finger that contain a combination of (i) designed recognition motifs that have been previously observed in ZFP-DNA structures and (ii) randomized positions where the desired binding specificity could not be predicted with high confidence (Supplementary Methods). Individual zinc-finger libraries were first selected in the context of two anchor zinc fingers with defined DNA-binding specificity 15 (Fig. 1a) . Each selection yielded a restricted pool of zinc fingers with motifs suitable for recognition of each 3-bp subsite ( Supplementary Fig. 3 online). Subsequently, the three independent zinc-finger pools that recognize each 3-bp subsite in the 9-bp recognition element were recombined by PCR to generate a new three-finger zinc-finger library 15 (Fig. 1b) . We then selected three-finger ZFPs specific for each 9-bp recognition element from these libraries ( Supplementary  Figs. 4 and 5 online) and identified two (ZFP1 and ZFP2) that displayed specificity for at least 7 out of the 9 bp in each of the target sequences within kdr exon 2 ( Fig. 1c and Supplementary Fig. 6 online). Based on the composite binding specificities of ZFP1 and ZFP2, the most suitable target site in the zebrafish genome for ZFNs containing these fingers is the desired target within kdr exon 2 (data not shown). Therefore, these ZFPs were incorporated into ZFNs for our studies.
The cassette encoding each ZFP was transferred into a pCS2 expression plasmid 19 containing a nuclear localization signal, an epitope tag and one of two complementary FokI cleavage domain variants (DD and RR versions, Fig. 1d and Supplementary Fig. 1a ). These modified FokI nuclease domains contain previously described mutations at the dimerization interface that reduce their propensity to homodimerize 21, 22 , thereby decreasing the frequency of off-target cleavage events due to homodimerization of an individual ZFN. To determine the efficacy of the engineered ZFNs in vivo, we injected mRNA encoding each heterodimeric ZFN together or separately at various concentrations into one-cell stage zebrafish embryos (Fig. 1d) . The majority of embryos injected with 5 pg of each kdr exon 2 ZFN displayed overall normal morphology at 24 h post fertilization (Fig. 2a) . Increasing amounts of both ZFNs led to nonspecific developmental abnormalities (referred to as 'monsters') and death (Fig. 2a,b) . We did not observe obvious cardiovascular defects known to be associated with loss of kdr 18 . This finding is consistent with previous studies demonstrating that ZFN-induced mutations usually occur in only one copy of a diploid genome, leading to heterozygosity 2 . Furthermore, embryos containing ZFN-induced mutations are mosaic (see below), which is likely to preclude the appearance of vascular-specific defects. Nonspecific abnormalities or lethality were not observed in embryos injected with similar doses of mRNA encoding either of the ZFN monomers (Fig. 2a) , suggesting that the observed defects were due to excessive off-target site DNA cleavage by the heterodimeric ZFN complex.
To determine whether the ZFNs caused site-specific mutations, we carried out PCR-based genotyping of injected embryos that displayed normal morphology. We used an NspI restriction site in the 6-bp spacer region between each ZFN 9-bp recognition element within kdr exon 2 ( Supplementary Fig. 1c ). As NHEJ can lead to short deletions 10, 17 as well as insertions, we would expect the exon 2 NspI site to be lost in injected embryos. PCR-amplified kdr exon 2 fragments from individual uninjected embryos show complete digestion with NspI (Fig. 2c) . By contrast, individual embryos coinjected with both ZFNs displayed a larger fragment consistent with the loss of the kdr exon 2 NspI site in a fraction of the total population (Fig. 2c) . These observations are consistent with a ZFN-directed mutagenic lesion at this site. To better characterize these lesions and quantify the mutagenesis frequency, we cloned and sequenced PCR fragments spanning kdr exon 2 from normal ZFN-treated embryos at 24 h post fertilization. We observed a variety of lesions comprising microdeletions (4, 5 and 6 bp) and small insertions (Fig. 2d) . In most cases, these deletions led to a frameshift in the kdr coding sequence that should result in a truncated Kdr protein (data not shown). From a pool of shotgun-cloned fragments, we identified lesions in 9 out of 94 clones, indicating that the ZFN-induced mutagenic frequency was B10% in morphologically normal embryos.
We used Solexa sequencing technology to estimate the frequency of ZFN-induced lesions at other genomic regions with sequence similarity to the kdr exon 2 target site. We assayed 41 potential off-target sites that varied from the kdr exon 2 target site by 1-4 bp (heterodimeric ZFN sites) or that could be bound through homodimerization of individual monomers (homodimeric ZFN sites). Using PCR, we amplified each off-target site as well as the target site from genomic DNA that we isolated from embryos injected with 10 or 20 pg of mRNA encoding both ZFNs or from uninjected embryos. PCR products from each ZFN dose were uniquely bar coded with Solexa adapters, pooled and then analyzed in a single Solexa sequencing run. Sequencing reads unique to each experimental condition were deconvoluted using the attached bar code. No insertions or deletions were observed at any sites in the uninjected embryos. In morphologically normal embryos injected with 10 pg of both ZFNs, we detected small insertions or deletions in B20% of target site fragments; only two off-target sites displayed similar lesions and these occurred at a frequency of B1% (Fig. 2e) . ZFN-induced lesions were 770-fold more likely to occur at the target site than at off-target sites (P ¼ 9.5 Â 10 À10 ; Supplementary Table 1 online). In 'monster' embryos from the 10-pg and 20-pg dose, there were more lesions at off-target sites but lesions at target sites were still B170-fold more frequent (Fig. 2e and Supplementary Table 1) . Consistent with our use of engineered FokI heterodimers that limit homodimerization 20,21 , we did not observe any lesions at sites expected to bind either ZFN homodimer in normal embryos (Supplementary Table 1 ). In summary, these results suggest that morphologically normal embryos injected with the kdr exon 2 ZFNs displayed specific lesions at the target site with only modest collateral mutagenesis to the genome. To determine whether ZFN-induced mutations could be transmitted through the zebrafish germ line, we raised embryos injected with 15 pg of mRNA encoding both ZFNs. Of 178 injected embryos, 69 were morphologically normal at 24 h post fertilization and 28 of these reached adulthood (see Supplementary Fig. 7 online for a summary of F 1 founder analysis). We found that fertilization rates of and embryo production from most ZFN-treated adults were similar to those of wild-type adults (Supplementary Tables 2 and 3 online and data not shown). In addition, we did not observe any increase in the appearance of nonspecific developmental abnormalities in embryos from ZFN-treated adults compared to wild type (e.g., Fig. 3 ; Supplementary Table 2 and Supplementary Fig. 8 online) . In two cases, we identified male founders that appeared to be sterile (Supplementary Tables 2 and 3). We identified putative founders bearing ZFN-induced mutations in kdr by crossing them to heterozygous carriers of the kdr um6 allele, an N-ethyl-N-nitrosourea-generated allele that leads to segmental artery defects. We examined progeny embryos for the presence of segmental arteries and blood circulation, both of which are absent in kdr mutant embryos 18 . To visualize segmental arteries, we used kdr um6 carriers bearing Tg(fli1:egfp) y1 that express enhanced green fluorescent protein (EGFP) in all endothelial cells to allow fluorescent visualization of blood vessels 22 . Embryos from 6 of 20 potential founders exhibited loss of segmental arteries and/or loss of circulation indicative of mutations within kdr. For example, embryos from founder 883.2M were phenotypically identical to those derived from an incross of kdr um6 heterozygous carriers (compare Fig. 3d,h ), whereas embryos from founder 889.3M displayed less severe segmental artery defects ( Fig. 3f ) similar to those associated with a hypomorphic kdr allele 18 . These observations suggest a qualitative difference between the ZFN-induced lesions at the kdr locus in these two founders. Based on the number of mutant embryos observed in outcrosses to kdr um6 heterozygotes, we estimated that germ-cell mosaicism in the identified ZFN allele-bearing founders ranged from 8 to 50% (Supplementary Table 2 ). Notably, this degree of penetrance remained consistent upon successive crosses, indicating that these mutations are stable within the zebrafish germ line (Supplementary Table 3) .
We genotyped individual embryos using the NspI assay described above ( Fig. 2c) to confirm that the observed vascular phenotypes were due to ZFN-induced mutations in kdr exon 2. For founders 883.2M, 889.3M and 889.7M, we observed a direct correlation between the appearance of an NspI-resistant fragment and circulatory defects ( Fig. 4a and Supplementary Fig. 9a ,b online). In all cases, circulatory defects correlated with trans-heterozygosity of the ZFN-induced and kdr um6 alleles (Fig. 4a, Supplementary Fig. 10 online and data not shown). The remaining founders had both NspI-resistant and NspIsensitive alleles. For example, only two of eight mutant embryos derived from founder 883.7F displayed loss of NspI digestion (Supplementary Fig. 9c ), suggesting the existence of multiple ZFNinduced mutant alleles. PCR analysis of mutant and wild-type sibling embryos using flanking primers revealed a smaller fragment indicative of a large deletion at the target site ( Supplementary Fig. 9d ). Subsequent sequence analysis confirmed the loss of 382 bp immediately upstream of the ZFN1 recognition element ( Supplementary  Fig. 9d and data not shown). Thus, founder 883.7F appears to carry two distinct kdr exon 2 mutant alleles. Mutant embryos from founder 889.1M also displayed an apparent wild-type NspI genotype (Fig. 4a) . In this case we used a CelI nuclease assay, which cleaves DNA at sites containing base mismatches, insertions or deletions 20, 23 , to detect potential mutations at the kdr exon 2 target site. PCR products amplified from wild-type embryos derived from founder 889.1M were not digested by CelI (Fig. 4b) . By contrast, PCR products from mutant embryos were sensitive to CelI digestion, indicating the presence of noncomplementary DNA sequences within these alleles due to ZFN-induced genetic lesions at kdr exon 2 (Fig. 4b) .
We further characterized the ZFN-induced lesions in kdr by cloning and sequencing PCR fragments containing exon 2 from pooled sibling mutant embryos ( Supplementary Fig. 7 ). Similar to somatic lesions characterized in injected embryos (Fig. 2d) ZFN-induced germline lesions included both deletions and insertions that overlapped the ZFN target site (Fig. 4c) . As expected from the NspI genotyping analysis, founders 883.2M and 889.3M displayed deletions that eliminated the NspI site (Fig. 4c) . In addition, the frequency of mutant alleles detected in a pooled embryo population (Supplementary Table 4 online) along with genotyping analysis ( Supplementary Fig. 9a ,b) suggested that these mutations were the only mutant alleles at kdr exon 2 carried by these respective founders. Embryos derived from founder 883.2M had a 4-bp deletion that would lead to a frameshift and a truncated kdr protein (data not shown). Notably, the deletion observed in mutant embryos derived from founder 889.3M displayed a 24-bp deletion that maintained the kdr reading frame. The milder segmental artery defect in embryos bearing this mutation was consistent with the generation of a hypomorphic kdr allele (Fig. 2) . In embryos derived from founders 889.1M and 889.7M, we detected insertions within the ZFN target site ( Fig. 4c and Supplementary Table 4) . As above, the frequency of these sequences within pooled mutant embryos suggested the existence of a single mutant allele derived from each founder (Supplementary Table 4 ). For founder 889.1M, a 4-bp insertion retained the NspI site, consistent with our NspI and CelI genotyping analysis (Fig. 4b,c) .
In embryos from founder 883.7F, a 12-bp deletion occurred at a low frequency within pooled mutant embryos. As described above, the 883.7F founder also bears a mutant allele characterized by a 382-bp deletion that would not be detected using our shotgun cloning strategy or preliminary NspI assay. These results indicate that all analyzed ZFN-injected founders harbored mutagenic lesions at the target site and, in all but one case, bore a single mutant allele. Using a combination of design and selection, we have created a pair of ZFNs that introduce mutations at a desired site within the zebrafish genome. In principle, existing libraries of preselected zinc-finger modules could be used to assemble ZFNs [12] [13] [14] 24 while bypassing the need for selection, as demonstrated for the Drosophila genome 9, 10 . However, existing databases of zinc fingers contain modules of variable quality 10, 11, 25 , and ZFNs constructed from these fingers may perform poorly, particularly in the context of complex vertebrate genomes. Until a library of in vivo validated finger modules is available, a combination of design and selection strategies will probably be necessary to generate ZFPs with the highest specificity. With our approach, ZFNs can be generated and characterized in vivo in B6-8 weeks. In principle, pairs of ZFNs for different targets can be created in parallel within this time frame with minimal expense.
Our findings suggest that targeted gene inactivation using ZFNs in zebrafish embryos is quite robust: nearly one-third of screened founders carried lesions at the target site, and half of the gametes in several founders carried a single mutagenic kdr allele. In our current work, we crossed our founders to an existing null kda allele to rapidly confirm the presence of targeted lesions. To generate mutations in genes for which no mutant lines exist, founders could be identified using a PCR-based assay similar to the one described here. Subsequent generations of embryos would then be raised to adulthood and incrossed to characterize the associated phenotype. Given the high degree of germline transmission observed here, preliminary phenotypic analysis could be performed by incrossing the initial founder fish. Therefore, generation of a family of heterozygous carriers of a desired ZFN-induced mutation would take B6 to 8 months after injection to establish founders.
Our work provides a foundation to perform focused gene modification in a vertebrate genome and should allow the development of techniques for more subtle genomic manipulation. Indeed, we show that by simply screening numerous founder individuals it is possible to identify distinct lesions ranging from frameshifts to small in-frame deletions. By focusing on functional domains within a protein of interest, our approach will allow straightforward generation of a targeted allelic series of mutants. Given the success of ZFN-targeted gene modification by homologous recombination in cell culture 2 , it should be feasible to achieve targeted knock-ins in zebrafish, with exciting implications for the creation of human disease models that were heretofore inaccessible. Finally, this technology does not rely on the existence of species-specific embryonic stem cell lines and should translate to other vertebrates, especially in cases where it is possible to harvest and easily manipulate fertilized embryos.
METHODS
Zebrafish husbandry and genetic modification. Zebrafish adults and embryos were handled according to standard methods 26 . These studies were approved by the UMass Medical School IACUC. The wild-type line used in this study (referred to as Crawfish) was established through several incross generations of wild-type fish originally obtained from Scientific Hatcheries. The kdr um6 allele was identified in an ongoing screen for vascular mutants (N.D.L., unpublished observations). Imaging of wild-type and Tg(fli1a:egfp) y1 embryos was performed as described elsewhere 18 . pCS2-ZFN constructs were linearized with NotI and mRNA was transcribed with SP6. We performed microinjection of ZFN mRNAs into one-cell-stage zebrafish embryos according to standard methods 27 . Phenotypic observation of segmental arteries and circulation as well as individual embryo genotyping was done as described previously 18 .
Omega-based bacterial one-hybrid selection of ZFPs. Briefly, output from the search algorithm ( Supplementary Fig. 2 ) was manually inspected for suitable ZFP recognition sequences. One site in exon 2 (5¢-ACACACCTTCAG CATGTTGGTGGGAC-3¢; ZFP recognition elements underlined) was deemed suitable based on the large fraction of purines within each ZFP site and the large proportion of bases that were guanines within these recognition elements. Zinc-finger libraries were constructed by cassette mutagenesis and their complexity assessed as previously described 28 except that the annealed library and complementary oligonucleotides were cloned into the desired zinc-finger module between two unique BbsI restriction sites that generate unique, nonpalindromic, 4-bp overhangs within the vector. A twostage selection approach (adapted from ref. 15 ) was used to select ZFPs from these libraries that recognize each element via an omega-based bacterial one-hybrid system 29 .
Zinc-finger library construction. Individual zinc fingers that recognize each subsite within the ZFP recognition element were selected independently from a library of partially randomized recognition helices in the context of two anchor zinc fingers, which, due to their defined specificity, ensure that the randomized zinc-finger library is positioned over the appropriate DNA-recognition element (Fig. 1a) . ZFP sequences were derived from Zif268 except at the altered recognition positions. Some of the recognition positions within each zincfinger library were fixed based on 'high confidence' interactions that were anticipated to be functional in most recognition contexts. The positions not fixed within each recognition helix (a subset of positions -1,1,2,3,5 and 6) were fully randomized (codon encoded NNK). ZFP libraries were constructed in pB1H2o2-an ampicillin-marked vector that expresses each ZFP as a fusion to the omega-subunit of RNA polymerase. Details on the individual zinc-finger libraries are described in Supplementary Methods.
Stage 1 B1H ZFP selections. Each ZFP library and the complementary reporter vector containing its target site were introduced into a selection strain that lacks endogenous expression of the omega subunit of RNA polymerase (US0DhisBD pyrFDrpoZ). For each selection, 150 ng of pB1H2oZFP library DNA and 150 ng of pH3U3 reporter DNA were cotransformed into the selection strain by electroporation. These cells were recovered and adapted to the His-selective (NM) minimal medium conditions following the previously described B1H selection protocol 28 . About 10 7 transformants were plated on an NM minimal medium plate (round 150 Â15 mm) lacking histidine and containing 0 or 10 mM isopropyl-b-D-thiogalactoside (IPTG) and 5 or 10 mM 3-AT. The selection plates were incubated at 37 1C for 1 or 2 d until a moderate number of colonies were easily discernable. Different ZFP libraries demonstrated different activities under the selection conditions. For example, the F1-GGA library displayed robust growth at low stringency, so colonies were selected from the high stringency plate (10 mM 3-AT, 0 mM IPTG), whereas the F2-GGT library displayed low activity, so colonies were selected from the low stringency plate (5 mM 3-AT, 10 mM IPTG). Ideally colony numbers in the hundreds would be obtained from each selection for recombination to build the final ZFP library for each recognition element. In these selections, from 35 (library F2-GGT) to 2,000 (library F1-GGA) colonies were recovered on the optimal selection plate. Eight colonies from each of these plates were picked and cultured and plasmid DNA was isolated and sequenced to identify the selected zinc fingers (sequencing primer: CAAGAGCAGGAAGCCGCTG, see Supplementary Fig. 3 ).
Stage 2 ZFP library assembly. Colonies from the desired selection plates were washed off the plates and their plasmid DNA was recovered as a pool as previously described 28 . Each pool of individual zinc fingers was amplified from the plasmid DNA by PCR: 50 ml reaction with 1 unit New England Biolabs (NEB) Taq DNA polymerase using 50 ng plasmid DNA template and 1 mM each primer (Supplementary Methods); denature for 1 min at 95 1C, 28 cycles consisting of 94 1C for 20 s, 55 1C for 20 s and 72 1C for 20 s, followed by a final extension at 72 1C for 6 min. The PCR products were run on a 1.5% agarose Tris-acetate-EDTA (TAE) gel, and the appropriate bands were excised and purified using a Qiagen PCR purification kit. A library of three-finger zinc-finger cassettes was assembled from pools of individual zinc-finger PCR products by overlapping PCR. PCR products from each individual zinc finger (B50 ng each) were used as templates in a 50-ml PCR reaction containing 1 unit NEB Taq DNA polymerase and 1Â Taq buffer with dNTPs. During the first six reaction cycles primers were not included in the reaction, which allows the individual zinc-finger products to assemble into three-finger cassettes. The PCR reaction conditions were as follows: denature at 95 1C The PCR products were run on a 1.5% agarose TAE gel and the appropriate band from each extension was excised and purified using a Qiagen PCR purification kit. These products were digested with NotI and BamHI and cloned into pB1H2o2 between the corresponding unique restriction sites to build the Stage 2 ZFP libraries (as described in ref. 29) . Each three-finger ZFP library contained more than 10 6 unique clones.
Stage 2 ZFP selections and characterization. Functional ZFPs that recognize the desired recognition elements were selected using the omega-based B1H system as described for the individual finger selections except that higher selection stringencies were employed: 0-10 mM IPTG and 10-20 mM 3-AT. From 100 to 5,000 colonies survived on the various selection plates from 10 7 transformants challenged at each stringency. ZFP clones specific for the GAAGGTGTG recognition element were sequenced from the 10 mM 3-AT, 10 mM IPTG stringency plate (about 5,000 colonies surviving, Supplementary  Fig. 4 ) and ZFP clones for the TTGGTGGGA recognition element were sequenced from the 10 and 20 mM 3-AT and 10 mM IPTG stringency plate (about 3,000 and 100 colonies survived on the two different stringencies respectively; Supplementary Fig. 5 ).
Two clones isolated from the GAAGGTGTG target selection (ZFP1 and ZFP3) and three clones isolated from the TTGGTGGGA target selection (ZFP2, ZFP4, ZFP5) were characterized using the omega-based B1H binding site selection system 29 . Binding sites recognized by these clones were isolated from a 28-bp randomized pH3U3 reporter library. Individual clones were sequenced and the recognition motif was identified by analyzing the sequences for an overrepresented motif using MEME 30 (see Supplementary Fig. 6 for the list of selected sequences). The recognition motifs of each ZFP are presented as Sequence logos 31 generated at the Weblogo site 32 .
Heterodimeric cleavage domains used in the ZFNs. The FokI nuclease domain was extracted by PCR from vector pST1374 (ref. 12) . Heterodimeric versions of this domain were generated by mutagenic PCR to create a pair of cleavage domains (D483R (RR) and R487D (DD)) in which interacting residues in the dimerization interface were swapped; these mutations have been previously described to reduce homodimeric cleavage activity and thereby reduce toxicity of ZFNs 20, 21 .
ZFN transcription template in pCS2. Triple FLAG and HA epitopes were amplified from vectors pHWF and pHFHW (The Drosophila Gateway Vector Collection), respectively, by PCR and a SV40 NLS with Kozak sequence was added upstream of each epitope. The NLS-FLAG/HA fragments were inserted between BamHI and XhoI in pCS2. After the insertion of the NLS-epitope elements into pCS2, the unique BamHI and KpnI sites were eliminated and new unique KpnI and BamHI sites were added after the NLS-FLAG/HA element to facilitate rapid subcloning of ZFPs from the B1H vectors. Each heterodimeric FokI cleavage domain was introduced into one NLS-epitope version of pCS2 (FokI-DD with FLAG and FokI-RR with HA) between the unique BamHI and XbaI sites, and each ZFP was introduced between the unique KpnI and BamHI sites.
ZFN induced mutation detection using SURVEYOR nuclease. The Surveyor Mutation Detection Kit (Transgenomic) was used to detect ZFN-induced mutations within kdr exon 2. PCR reactions (25 ml) were carried out using 0.5 units Phusion Hot Start high fidelity DNA polymerase (Finnzymes) in the manufacturer-supplied buffer with 0.2 mM dNTPs and 1 mM primers flanking the exon 2 ZFN target site (5¢-GTTTGTGTTGTTAGTGTGCCTGTGATG TAATG-3¢, 5¢-ATAAAGTGGCCATTGAACGTAGATGCAC-3¢). This amplification should produce a 230-bp DNA fragment with the ZFN target site at its center. About 30 ng genomic DNA was used as the template in each PCR reaction. PCR reaction program: denature at 98 1C for 20 s followed by 35 cycles consisting of 98 1C for 10 s, 60 1C for 20 s and 72 1C for 15 s; 72 1C for 8 min final extension; 3 ml of each PCR product was assayed on a 1.5% TAE agarose gel to confirm successful amplification. The remaining PCR product was hybridized following the protocol in the Surveyor manual. We assayed 4-8 ml of the hybridized DNA for inhomogeneity by adding 0.5 ml Surveyor Enhancer S and Surveyor nuclease S each per 4 ml of DNA and incubating the reaction at 42 1C for 20 min. After incubation, 1 ml of loading dye was added to each reaction tube and 2.5% agarose TAE gel was run at 90 V for about 1 h. The gel was subsequently stained with SYBR Gold (Invitrogen) for about 30 to 60 min and then destained with H 2 O for about 20 min. DNA in the gel was visualized at 302 nm using a SYBR Gold filter.
Sequence analysis of mutations induced by ZFNs at kdr exon 2 in zebrafish embryos. Genomic DNA from 24 embryos without obvious developmental defects was isolated and pooled. A 646-bp PCR fragment containing exon 2 was amplified by PCR (5¢-GCAGAATTCAAACACAAGCACCGTCAGGAGCA CAAGTCC-3¢, 5¢-GCATGCGGCCGCGTTCACTGTACTCGAATGGCCTCCA CAGTC-3¢) and purified. This PCR fragment was digested with EcoRI and NotI and cloned into pBluescript II SK+ at the corresponding sites. This library of Exon 2 segments was transformed into XL1-Blue cells (Stratagene) and cells were plated on media containing X-gal (5-bromo-4-chloro-3-indolyl-b-D-galactoside). White colonies were picked and the cloned PCR product was amplified using Taq DNA polymerase and T3/T7 primers following the manufacturer's protocol. We sequenced 95 independent clones with the T7 primer to determine the type and distribution of lesions at exon 2.
Off-target site identification. Off-target sites with the highest propensity to be recognized by the exon 2 ZFNs were identified by searching the genome (Zv7 repeat-masked) for matches to the consensus sequence for each ZFP based on their determined specificity ('GAXGGTGTG' and 'XXGGTGGGA' , where X allows any base) with the appropriate spacing (5 or 6 bp) and orientation using a Perl algorithm. Heterodimer off-target sites were derived from sites that match 14 of 15 bp (kdr exon 2 is the only 15-of-15-bp match). Homodimeric sites were derived from sites that match either the 'GAXGGTGTG' composite site at 14 or 15 out of 16 bp or the 'XXGGTGGGA' composite site at 14 of 14 bp. A list of these sites is provided in Supplementary Table 5 online.
Off-target site lesion analysis. To assay lesion frequency at off-target sites, we performed Solexa sequencing of PCR fragments containing these sequences from zebrafish embryos. We injected wild-type zebrafish embryos with mRNA encoding both kdr exon 2 ZFNs at a dose of 10 and 20 pg per embryo. At B26 h post fertilization we separated embryos based on morphology (normal or 'monster') and isolated genomic DNA using the Qiagen DNAeasy kit. As a control, we isolated genomic DNA from uninjected sibling embryos. We then PCR-amplified 41 putative off-target sequences from embryos that were uninjected, injected with 10 pg ZFN and normal, injected with 10 pg ZFN and monster, and injected with 20 Table 5 ; all primers contain an AcuI site. In parallel, we PCR-amplified the kdr exon 2 target site from genomic DNA from each set of embryos using the following primers: Forward, 5¢-CCTGATCCACAACTGCTTCCTGATGGATATCCAC. Reverse, 5¢-ATAAAGTGGCCATTGAACGTAGATGCAC. After amplification, the off-site PCR products were pooled together and digested with AcuI (NEB) to remove the terminal 16 bp of the PCR product that is complementary to the genomic sequence, which allows sequencing to begin close to the putative lesion site. The on-site target fragment was separately digested with EcoRV (boldface sequence in forward primer). Enzyme digests were heat-inactivated and a proportional amount of on-site target was mixed with the appropriate off-site pool. Each fragment pool was then gel-purified and treated with T4 DNA polymerase (NEB) with dNTPs to remove 3¢ overhangs created by AcuI digestion. Polished fragments were purified using a Qiaquick column, treated with Klenow exoand dATP to add a 3¢ A overhang, and purified again using a Qiaquick column. We subsequently ligated adaptors containing a two-nucleotide 'bar code' unique to each injection condition: AA, uninjected; AC, 10 pg ZFN/monster embryos; AG, 10 pg ZFN/normal embryos; AT, 20 pg/monster embryos (adaptor sequences are listed in Supplementary Methods). Adaptor-ligated PCR products were then pooled together, gel purified and PCR amplified using Illumina Genomic DNA primers (Illumina). The resulting PCR product was subjected to deep sequencing on a Solexa 1G located at the Center for AIDS Research, University of Massachusetts Medical School.
Solexa data analysis. The Firecrest and Bustard analysis module (Illumina) was used for image analysis and base calling to generate the sequence reads. This population was filtered for matches and to a 7-bp 'prefix' that is unique to the sequence flanking the target site and to each of the 41 different off-target sites that were examined. Sequence reads that were uniquely aligned to one of these 42 potential sequences were subsequently binned into 176 different groups based on the 2-bp bar code that precedes each read, where four different bar codes were used with each representing a different ZFN dose. Thus, for each ZFN treatment there are 42 groups of sequences representing each population of the 41 off-target site sequences and the target site sequence group.
The presence of insertions and deletions in the sequences in each bin was identified by scanning for a 7-bp 'prefix' at the 5¢ end of each sequence before the spacer between the ZFP recognition sequences and a 7-bp 'suffix' at the 3¢ end of the distal ZFP binding site. The distance between the prefix and suffix pair in each sequence was determined. If the distance matched the expected sequence these sequences were binned as 'correct' , distances that were greater were binned as 'insertions' and distances that were shorter were binned as 'deletions' . This analysis will miss insertions or deletions that alter either the prefix or suffix, and consequently only a subset of the potential lesions are being sampled. However, this approach is robust with regard to excluding marginal sequence reads and avoids attempts to 'interpret' single bp mutations, which could result from sequencing errors or single nucleotide polymorphisms. The number of sequence reads that contain normal sequence reads and the number of sequences with indels (insertions plus deletions) at target and off-target sites for each ZFN dose were computed for the subsequent statistic analysis.
The Fisher exact test was applied to assess whether the target site has a different insertion/deletion rate compared to that of the off-target sites for each ZFN dose. The odds ratio and its 95% confidence interval was computed for each ZFN dose using the fisher.test function in version 2.5 of the R programming language based on conditional maximum likelihood estimation. The same function was also applied to evaluate whether there is an overall significant difference among all treatments including the control group in the insertion/deletion rate of the off-target sites. When a significant overall difference was detected (P o 0.05), Fisher exact test was performed to determine whether each individual treatment affects the insertion/deletion rate at the off-target sites compared with the control group.
Sequence analysis of mutant zebrafish offspring from potential founders. Genomic DNA from each embryo that lacked circulation at 48 h post fertilization was purified and the region surrounding exon 2 was amplified by PCR using the primers and protocol described above for the pooled embryo analysis. We pooled together 5 ml of PCR product from the embryos of each founder (six embryos from 889.1 male founder, six embryos from 883.7 female founder, 3 embryos from 889.7 male founder, six embryos from 889.3 male founder and six embryos from 883.2 male founder), purified, digested and cloned into pBluescript II SK+ as described above. About 38 white colonies from each pool of founder DNA were amplified with T3 and T7 primers using Taq DNA polymerase and these PCR products were directly sequenced using the T7 primer.
NspI analytical digestion of putative kdr exon 2 lesions induced by ZFNs. A 646-bp fragment containing kdr exon 2 was amplified using the primer set described for the sequence analysis of mutations at kdr exon 2 in an 11-ml PCR reaction, as described above. We analyzed 1 ml of each PCR product on 1.2% agarose gel to confirm successful amplification and the remaining 10 ml PCR product was mixed with 10 ml NspI digestion solution (2Â NEB buffer 2, 2Â BSA, 1.25 units of NspI, NEB) and incubated at 37 1C overnight. These reactions were analyzed on 2% agarose gel to assess cleavage of these PCR fragments.
PCR analysis of the ZFN-induced 382-bp deletion in 883.7. Primers 1 kb upstream of exon 2 target site (5¢-AGCGAATTCCGAATGTCACCCATCCT GAGCAGCA-3¢) and 100 bp downstream of target site (5¢-ATAAAGTGGC CATTGAACGTAGATGCAC-3¢) were used to amplify the genomic DNA of embryos displaying kdr À/À phenotypes. These PCR products were analyzed on a 1.2% agarose gel. The majority of mutant embryos from this founder displayed two amplification products of different size. A representative smaller PCR from one embryo was isolated, purified and sequenced using the 3¢ primer.
Note: Supplementary information is available on the Nature Biotechnology website.
